The most recent Success stories from EU Research. Select a theme or country from the menus on the left to see more articles
Health & life sciences - Molecular biology
Tick (check) box to add article to PDF "basket"
Multiple myeloma is a rare and incurable type of cancer that affects cells in the bone marrow called plasma cells. An EU-funded project is using revolutionary cell technology to tackle multiple myeloma, developing a viable and commercially attractive treatment for it and other rare diseases.
Published: 30 April 2019
EU-funded researchers have conducted the first successful trials of an innovative gene therapy to treat a rare and debilitating metabolic disorder, using a small and innocuous virus as a carrier for genetic information to correct the functioning of liver and muscle cells.
Published: 3 April 2019
Peptidomimetics are small molecules that mimic short natural proteins - peptides - and produce the same effects as their natural counterparts. An EU-funded project is developing peptidomimetics that can alternate between biologically active and inactive forms when exposed to light. The technique could lead to new light-controlled drugs which can be turned off and on when needed to treat cancers and other diseases.
Published: 4 March 2019
EU-funded researchers are developing pioneering tools and techniques that will enable scientists to view chromosomes in unprecedented detail, greatly advancing research into life-saving treatments for cancer and cures for many genetic disorders.
Published: 26 February 2019
A new generation of particle accelerators will help physicists explore the mysteries of the universe, provide engineers with novel tools to combat pollution and enable doctors to treat cancer more effectively. An EU-funded project is leading the advance, developing technologies that are set to have a profound impact on science and society.
Published: 30 November 2018
The EU-funded SWEETOOLS project aims to improve our understanding of the role of sugars in human biology. Exploring optimised versions of biosynthesised proteins combined with chemically synthesised drugs could help the development of novel biomedicines and vaccines targeting, for example, influenza.
Published: 22 November 2017
EU-funded researchers are working on novel, more effective contrast agents - the substances that make the contrast between, for example, muscle and bone, in MRI scans. This new level of detail will improve diagnostics and help ensure people receive the right treatment.
Published: 17 November 2017
Published: 10 November 2017
The NOMORFILM project is looking into whether biomolecules in marine microalgae can combat bacterial and fungal infections associated with prosthetic devices and catheters. Preventing infections will improve patient care and help cut the cost of treating complications, estimated at € 7 billion a year in Europe.
Published: 4 February 2016